Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2013
03/14/2013US20130064867 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine
03/14/2013US20130064865 Therapy to reduce extravasation damage
03/14/2013US20130064864 Submicron particles to decrease transfusion
03/14/2013US20130064852 Vaccine against mycoplasma, hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
03/14/2013US20130064850 Using Modified Plasmids to Suppress Antibiotic Resistant Pathogens
03/14/2013US20130064848 Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon
03/14/2013US20130064846 Neisserial antigens
03/14/2013US20130064845 Bacterial vaccine components from staphylococcus aureus and uses thereof
03/14/2013US20130064844 Non-splicing variants of gp350/220
03/14/2013US20130064843 Identification of conserved peptide blocks in homologous polypeptides
03/14/2013US20130064839 Method of rapidly producing improved vaccines for animals
03/14/2013US20130064828 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease
03/14/2013US20130064818 Use of immunesuppressant receptor
03/14/2013US20130064809 Antimicrobial Composition and Uses Thereof
03/14/2013US20130064796 Methods for the prevention and control of pathogenic infections in bees and relative composition
03/14/2013US20130064795 Immune modulation
03/14/2013US20130064794 Substituted Carbonyloxymethylphosphoramidate Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections
03/14/2013US20130064793 Compounds and pharmaceutical compositions for the treatment of viral infections
03/14/2013US20130064791 Interferon Analogs
03/14/2013US20130064790 Peptides with the capacity to bind to interleukin-10 (il-10)
03/14/2013US20130064787 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
03/14/2013US20130064777 Surfactant-free water-free foamable compositions, breakable foams and gels their uses
03/14/2013US20130064761 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
03/14/2013US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody
03/14/2013CA2848163A1 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine
03/14/2013CA2848117A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
03/14/2013CA2847888A1 Methods and compositions for controlling assembly of viral proteins
03/14/2013CA2847019A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
03/14/2013CA2846870A1 A conditional replicating cytomegalovirus as a vaccine for cmv
03/13/2013EP2568046A1 MicroRNAs from human herpesvirus 6
03/13/2013EP2567965A1 Derivatives of 3-O-(3',3'-dimethylsuccinyl)-betulinic acid
03/13/2013EP2567963A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound
03/13/2013EP2567960A2 Imidazo[1,2-a]pyrazine compounds for treatment of viral infections such as hepatitis
03/13/2013EP2567710A1 Aqueous pharmaceutical system for the administration of drugs to the nails
03/13/2013EP2567702A1 A particulate system comprising lanthanides for use in diminishing cell growth/inducing cell killing
03/13/2013EP2567691A1 Aqueous compositions comprising arbekacin
03/13/2013EP2566884A2 Genetic signatures in hiv-1 subtype c envelope glycoproteins
03/13/2013EP2566872A1 Compounds for the treatment of hepatitis c
03/13/2013EP2566863A1 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof
03/13/2013EP2566854A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
03/13/2013EP2566521A2 Immunogen adherence and method of making and using same
03/13/2013EP2566518A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
03/13/2013EP2566508A2 Polysaccharide conjugation with detoxified e. coli heat labile enterotoxin (lt) used as vaccine
03/13/2013EP2566498A1 Compounds, medicaments and methods of treatment for helicobacter pylori infection.
03/13/2013EP2566488A2 Povidone-iodine topical composition
03/13/2013EP2566484A2 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
03/13/2013EP2489735A9 Aptamer capable of binding to viral hemorrhagic septicemia virus
03/13/2013CN202774455U Disease prevention and treatment insole containing traditional Chinese medicine
03/13/2013CN1805966B Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
03/13/2013CN1578785B Novel immunogenic compositions for the prevention and treatment of meningococcal disease
03/13/2013CN1519311B Lawsonia intracellularis cultivation, anti-lawsonia intracelluaris vaccines and diagnostic agents
03/13/2013CN102971425A Live attenuated chimeric porcine circovirus vaccine
03/13/2013CN102971308A Non-nucleoside reverse transcriptase inhibitors
03/13/2013CN102971305A Heterocyclic antiviral compounds
03/13/2013CN102971301A 6 - methyl - 4 - phenyl - 5 - ( phenyl or cycloalkyl) carbamoyl - 1,2,3, 4 - tetrahydropyrimidin- 2 - one derivatives as antitubercular agents
03/13/2013CN102971011A Vaccine compositions based on sticholysin encapsulated in liposomes
03/13/2013CN102971004A Compounds, medicaments and methods of treatment for helicobacter pylori infection.
03/13/2013CN102970987A Methods of delivering a health care active by administering personal health care articles comprising a filament
03/13/2013CN102967662A Detection method for pharmaceutical composition for treating viral hepatitis
03/13/2013CN102965376A N-(3-oxo-dodecanoyl)-L-homoserine lactone aptamer, its screening method and application
03/13/2013CN102965348A Bovine viral diarrhea-mucosal virus with modified erns protein
03/13/2013CN102965345A Porcine parvovirus, vaccine composition and application thereof
03/13/2013CN102965344A Production of infectious bronchitis virus and vaccine from cell line
03/13/2013CN102965341A Immortalized human umbilical cord mesenchymal stem cell line, and construction method and application thereof
03/13/2013CN102965332A Swine testicular clone cell line and production method of classical swine fever live vaccine
03/13/2013CN102965268A Cold-preventing health-preserving vinegar
03/13/2013CN102964434A Recombinant encephalitis B virus and application thereof
03/13/2013CN102964433A High immunogenicity rabies virus glycoprotein, its preparation method and application
03/13/2013CN102964432A Method for restraining phosphorylation of M1 protein of influenza virus A and applications of method
03/13/2013CN102964409A Stable needle-shaped crystals of natamycin
03/13/2013CN102964402A Dehydro-clindamycin-free clindamycin hydrochloride and preparation method and applications thereof
03/13/2013CN102964401A Method for preparing clindamycin phosphate
03/13/2013CN102964400A Preparation method and applications of dehydro-lincomycin-free lincomycin hydrochloride
03/13/2013CN102964384A Adefovir dipivoxil gallic acid eutectic, and preparation method and composition thereof
03/13/2013CN102964357A Faropenem sodium and tablet thereof
03/13/2013CN102964350A 7-hexahydropyrrolo[1, 2-a]pyrazinylquinolonecarboxylic acid derivative and its application in treatment of Helicobacter pylori infections
03/13/2013CN102964348A New meropenem crystal form and preparation method thereof
03/13/2013CN102964326A Compound with MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as preparation method and application of compound
03/13/2013CN102964321A Nepetalactone fluorobenzoate, preparation technology and usage thereof
03/13/2013CN102964267A Cyclohexene compound having influenza virus neuraminidase inhibition activity, preparation method and application
03/13/2013CN102964264A Preparation method of natural general alkaloids of capsicum annuum
03/13/2013CN102964239A Metallo-beta-lactamase inhibitor
03/13/2013CN102964238A Bipolar trans-carotenoid salt and application thereof
03/13/2013CN102961757A Pseudovirus particle vaccine carrying double-stranded RNA target antigen and neutralizing antigen
03/13/2013CN102961743A Recombinant Newcastle disease LaSota attenuated vaccine strain expressing mycoplasma gallisepticum TM1protein
03/13/2013CN102961742A Bivalent inactivated vaccine of porcine circovirus type 2 and porcine parvovirus and preparation method thereof
03/13/2013CN102961741A Method for preparing tetanus toxoid vaccine
03/13/2013CN102961740A Preparation method of diphtheria toxoid vaccine
03/13/2013CN102961737A Application of polypeptide DZ24 in preparation of medicine for treating goat bacteria or fungal inflammation
03/13/2013CN102961736A Application of goat antibacterial peptide GC41
03/13/2013CN102961723A Traditional Chinese medicine composition for treating pediatric viral myocarditis
03/13/2013CN102961713A Ginger and garlic enteric-coated tablet and preparation method thereof
03/13/2013CN102961701A Orally administered traditional Chinese medicine composition for treating viral myocarditis
03/13/2013CN102961693A Composition for treating cold
03/13/2013CN102961686A Oral liquid for treating canine distemper and preparation method of oral liquid
03/13/2013CN102961681A Chinese patent medicine for treating viral myocarditis
03/13/2013CN102961668A Feed additive for preventing and treating fowl plague and preparation method thereof
03/13/2013CN102961661A Compound preparation for treating upper respiratory infection and tracheitis
03/13/2013CN102961660A Chinese herbal medicine for treating fish diseases
03/13/2013CN102961655A Externally used pharmaceutical composition for treating eruption